Opko Health (OPK) Cash from Investing Activities (2010 - 2026)

Opko Health (OPK) has 17 years of Cash from Investing Activities data on file, last reported at $15.5 million in Q2 2026.

• Quarterly Cash from Investing Activities rose 648.2% year-over-year to $15.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $206.3 million (down 21.35% YoY) and the FY2025 annual result came in at $230.3 million, down 34.61% from the prior year.
• Cash from Investing Activities climbed to $15.5 million in Q2 2026, from -$1.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $236.2 million in Q3 2024 to a low of -$11.6 million in Q2 2024.
• A 5-year average of $31.6 million and a median of -$2.8 million in 2025 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 343.31% — and 2024, when it soared 6713.3%.
• Tracing OPK's Cash from Investing Activities over 5 years: stood at -$7.9 million in 2022, then surged by 81.99% to -$1.4 million in 2023, then soared by 16759.17% to $236.2 million in 2024, then slumped by 100.87% to -$2.0 million in 2025, then soared by 859.34% to $15.5 million in 2026.
• The last three Cash from Investing Activities figures came in at $15.5 million (Q2 2026), -$1.8 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.